Published in:

01-04-1999 | Original Article

Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes and Subcutaneous Recombinant Interleukin-2 Plus Interferon Alfa-2a for Melanoma Patients With Nonresectable Distant Disease: A Phase I/II Pilot Trial

Authors: Paola Queirolo, MD, Marco Ponte, MD, Marco Gipponi, MD, Ferdinando Cafiero, MD, Alberto Peressini, MD, Claudia Semino, PhD, Gabriella Pietra, PhD, Rita Lionetto, MD, Stefania Vecchio, MD, Iole Ribizzi, MD, Giovanni Melioli, MD, Mario R. Sertoli, MD, Melanoma Istituto Scientifico Tumori Group

Published in: Annals of Surgical Oncology | Issue 3/1999